Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3751)
All Articles published online
|
Feb 27, 2010 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kew MC. Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol 2010; 2(2): 65-73 [PMID: 21160975 DOI: 10.4254/wjh.v2.i2.65] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v2/i2/65.htm |
| Number | Citing Articles |
| 1 |
D. Alan Herbst, K. Rajender Reddy. Risk factors for hepatocellular carcinoma. Clinical Liver Disease 2012; 1(6): 180 doi: 10.1002/cld.111
|
| 2 |
Jacquelyn Carr, Da Eun Cha, Tali Shaltiel, Serena Zheng, Cleo Siderides, Benjamin Golas, Daniel Labow, Deepa Magge, Noah Cohen, Andrea Branch, Umut Sarpel. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality. Journal of Immigrant and Minority Health 2022; 24(2): 327 doi: 10.1007/s10903-021-01205-8
|
| 3 |
Catherine MN Croagh, Paul V Desmond, Sally J Bell. Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. World Journal of Hepatology 2015; 7(3): 289-303 doi: 10.4254/wjh.v7.i3.289
|
| 4 |
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
|
| 5 |
Bertrand Livinec. Estimating the burden of hepatitis. The Lancet 2016; 388(10061): 2738 doi: 10.1016/S0140-6736(16)31649-X
|
| 6 |
Marie Amougou Atsama, Paul Jean Adrien Atangana, Dominique Noah Noah, Paul Fewou Moundipa, Pascal Pineau, Richard Njouom. Hepatitis E virus infection as a promoting factor for hepatocellular carcinoma in Cameroon: Preliminary Observations. International Journal of Infectious Diseases 2017; 64: 4 doi: 10.1016/j.ijid.2017.08.010
|
| 7 |
Philippa C. Matthews, Anna Maria Geretti, Philip J.R. Goulder, Paul Klenerman. Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa. Journal of Clinical Virology 2014; 61(1): 20 doi: 10.1016/j.jcv.2014.05.018
|
| 8 |
Weiqi Xu, Jun Yu, Vincent Wai-Sun Wong. Mechanism and prediction of HCC development in HBV infection. Best Practice & Research Clinical Gastroenterology 2017; 31(3): 291 doi: 10.1016/j.bpg.2017.04.011
|
| 9 |
Jin Zhang, Changwei Hu, Xiaoxiao Xie, Linzhi Qi, Chuanzhou Li, Shangze Li. Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy. Vaccines 2023; 11(3): 614 doi: 10.3390/vaccines11030614
|
| 10 |
Amal Saad-Hussein, Haidi Karam-Allah Ramadan. Impact of Climate Change on Health in Africa. 2023; : 53 doi: 10.1007/978-3-031-39466-9_3
|
| 11 |
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patients. Comparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
|
| 12 |
Hatim M.Y. Mudawi, Suliman S. Fedail, Mabula Mchembe, Najet Bel Hadj, Ibrahim Mostafa, Magid Kagimu, Walid Sweidan, Ali Mahamat Moussa, Olusegun S. Ojo, Meshesha Berhane Redae, Negassi Leake, Yasser Abu-Safieh, Engida Abebe Gelan, Oluwole Olaomi, Choua Ouchemi, Ponsiano Ocama, Samir Ismail, Chris J. Mulder, Abdel Meguid Kassem. The African Middle Eastern Society for Digestive Oncology mission against viral hepatitis and hepatocellular carcinoma. Arab Journal of Gastroenterology 2013; 14(1): 31 doi: 10.1016/j.ajg.2012.12.003
|
| 13 |
Marie Atsama Amougou, Paul Jean Adrien Atangana, Alice Ghislaine Ndoumba Afouba, Paul Fewou Moundipa, Pascal Pineau, Richard Njouom. Dichotomous associations of liver pathology with hepatocellular carcinoma morphology in Middle Africa: the situation in Cameroon. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3560-x
|
| 14 |
Josh Hanson, Sharna Radlof, Margaret Littlejohn, Allison Hempenstall, Ros Edwards, Yoko Nakata, Sandra Gregson, Richard Hayes, Simon Smith, Melita McKinnon, Paula Binks, Steven Y. C. Tong, Jane Davies, Joshua S. Davis. Hepatitis B genotypes in Aboriginal and Torres Strait Islander Australians: correlation with clinical course and implications for management. Internal Medicine Journal 2024; 54(4): 647 doi: 10.1111/imj.16181
|
| 15 |
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review). Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
|
| 16 |
Mohammad Asim, Manash Pratim Sarma, Premashis Kar. Etiological and molecular profile of hepatocellular cancer from India. International Journal of Cancer 2013; 133(2): 437 doi: 10.1002/ijc.27993
|
| 17 |
Kaushal Madan, Pankaj Tyagi. Hepatitis B Virus Genotyping: Is the Time Ripe for Routine Clinical Use?. Journal of Clinical and Experimental Hepatology 2012; 2(2): 174 doi: 10.1016/S0973-6883(12)60105-4
|
| 18 |
V. V. Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, Stephen Kimani, Ashraf Omar Abdelaziz, Elizabeth Yu Chiao, Ghassan K. Abou-Alfa. Hepatocellular Carcinoma in Sub-Saharan Africa. JCO Global Oncology 2021; (7): 756 doi: 10.1200/GO.20.00425
|
| 19 |
Kimberly A. Forde, Orapin Tanapanpanit, K. Rajender Reddy. Hepatitis B and C in African Americans: Current Status and Continued Challenges. Clinical Gastroenterology and Hepatology 2014; 12(5): 738 doi: 10.1016/j.cgh.2013.06.006
|
| 20 |
Thomas Chen, Fiona Borondy-Jenkins, Beatrice Zovich, Suzanne J. Block, Kate Moraras, Alice Chan, Chari Cohen. Existing knowledge, myths, and perceptions about hepatitis B and liver cancer within highly impacted immigrant communities. Journal of Virus Eradication 2024; 10(2): 100379 doi: 10.1016/j.jve.2024.100379
|
| 21 |
Donatien Serge Mbaga, Sebastien Kenmoe, Cyprien Kengne-Ndé, Jean Thierry Ebogo-Belobo, Gadji Mahamat, Joseph Rodrigue Foe-Essomba, Marie Amougou-Atsama, Serges Tchatchouang, Inès Nyebe, Alfloditte Flore Feudjio, Ginette Irma Kame-Ngasse, Jeannette Nina Magoudjou-Pekam, Lorraine K. M. Fokou, Dowbiss Meta-Djomsi, Martin Maïdadi-Foudi, Sabine Aimee Touangnou-Chamda, Audrey Gaelle Daha-Tchoffo, Abdel Aziz Selly-Ngaloumo, Rachel Audrey Nayang-Mundo, Jacqueline Félicité Yéngué, Jean Bosco Taya-Fokou, Raoul Kenfack-Momo, Efietngab Atembeh Noura, Cynthia Paola Demeni Emoh, Hervé Raoul Tazokong, Arnol Bowo-Ngandji, Carole Stéphanie Sake, Etienne Atenguena Okobalemba, Jacky Njiki Bikoi, Richard Njouom, Sara Honorine Riwom Essama, Do Young Kim. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders. PLOS ONE 2022; 17(1): e0262903 doi: 10.1371/journal.pone.0262903
|
| 22 |
Ming Ren Toh, Evelyn Yi Ting Wong, Sunny Hei Wong, Alvin Wei Tian Ng, Lit-Hsin Loo, Pierce Kah-Hoe Chow, Joanne Ngeow. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 2023; 164(5): 766 doi: 10.1053/j.gastro.2023.01.033
|
| 23 |
Sanju Sobnach, Urda Kotze, C. Wendy Spearman, Mark Sonderup, Pueya R. Nashidengo, Chikwendu Ede, Elie Keli, Onesai Chihaka, Luiz F. Zerbini, Yifan J. Li, Karan Gandhi, Jake Krige, Eduard Jonas. The management and outcomes of hepatocellular carcinoma in sub-Saharan Africa: a systematic review. HPB 2024; 26(1): 21 doi: 10.1016/j.hpb.2023.09.015
|
| 24 |
R. Ntagirabiri, T. Niyongabo, A. Ndayiragije, E. Baransaka. Prévalence du virus de l’hépatite B au Burundi sur la base d’une enquête nationale. Journal Africain d'Hépato-Gastroentérologie 2013; 7(4): 199 doi: 10.1007/s12157-013-0495-7
|
| 25 |
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
|
| 26 |
Sudeep Tanwar, Geoffrey Dusheiko. Is There Any Value to Hepatitis B Virus Genotype Analysis?. Current Gastroenterology Reports 2012; 14(1): 37 doi: 10.1007/s11894-011-0233-5
|
| 27 |
Eliana Castillo, Kellie Murphy, Julie van Schalkwyk. N° 342-L'hépatite B et la grossesse. Journal of Obstetrics and Gynaecology Canada 2017; 39(3): 191 doi: 10.1016/j.jogc.2017.01.018
|
| 28 |
K. Sartorius, B. Sartorius, C. Aldous, P.S. Govender, T.E. Madiba. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiology 2015; 39(3): 284 doi: 10.1016/j.canep.2015.04.006
|
| 29 |
Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani. Role of iron in hepatocellular carcinoma. Clinical Liver Disease 2014; 3(5): 108 doi: 10.1002/cld.350
|
| 30 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 31 |
Eliana Castillo, Kellie Murphy, Julie van Schalkwyk. No. 342-Hepatitis B and Pregnancy. Journal of Obstetrics and Gynaecology Canada 2017; 39(3): 181 doi: 10.1016/j.jogc.2016.11.001
|
| 32 |
Jung Wha Chung, Eun Shin, Haeryoung Kim, Ho‐Seong Han, Jai Young Cho, Young Rok Choi, Sukho Hong, Eun Sun Jang, Jin‐Wook Kim, Sook‐Hyang Jeong. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection. Liver International 2018; 38(5): 903 doi: 10.1111/liv.13619
|
| 33 |
Mohube B. Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E. Simani, Tongai G. Maponga, Patrick Arbuthnot. Hepatitis B Virus Research in South Africa. Viruses 2022; 14(9): 1939 doi: 10.3390/v14091939
|
| 34 |
Kurt Sartorius, Benn Sartorius, Cheryl Winkler, Anil Chuturgoon, Tsai-Wei Shen, Yongmei Zhao, Ping An. Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. International Journal of Molecular Sciences 2024; 25(2): 975 doi: 10.3390/ijms25020975
|
| 35 |
Lesley A. Patmore, Kirsi M.A. van Eekhout, Maria Buti, Özgur.M. Koc, Kosh Agarwal, Rob J. de Knegt, Harry L.A. Janssen, Marc van der Valk, Faydra I. Lieveld, Bettina E. Hansen, Matthijs Kramer, Joep de Bruijne, Mark A.A. Claassen, Colette Smit, Rob A. de Man, Bart Takkenberg, Ivana Carey, Milan J. Sonneveld. Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe. Journal of Hepatology 2024; 80(2): 243 doi: 10.1016/j.jhep.2023.10.019
|
| 36 |
Henry Bautista-Amorocho, Yeny Zulay Castellanos-Domínguez, Laura Andrea Rodríguez-Villamizar, Sindi Alejandra Velandia-Cruz, Jeysson Andrey Becerra-Peña, Ana Elvira Farfán-García, Jason Blackard. Epidemiology, Risk Factors and Genotypes of HBV in HIV-Infected Patients in the Northeast Region of Colombia: High Prevalence of Occult Hepatitis B and F3 Subgenotype Dominance. PLoS ONE 2014; 9(12): e114272 doi: 10.1371/journal.pone.0114272
|
| 37 |
Jing-Hua Fan, Xiao Li, Yang Tang, Xin Lai, Xi Li, Liang Zhang, Tai-Cheng Zhou, Jia Wei. Molecular Characterization of Coexistence of HBsAg and Anti-HBs in a Patients Infected with HBV Genotype I. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.81740
|
| 38 |
Tinsay A. Woreta, James P. Hamilton. Primary Liver Cancer. 2012; : 1 doi: 10.1007/978-1-61779-863-4_1
|
| 39 |
Nayantara Orekondy, Sheila Eswaran. Misconceptions Surrounding Hepatocellular Carcinoma. Clinical Liver Disease 2018; 12(6): 154 doi: 10.1002/cld.752
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 41 |
Daniel Mak, Chantal Babb de Villiers, Charles Chasela, Margaret I. Urban, Anna Kramvis, Jason Blackard. Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000–2012. PLOS ONE 2018; 13(5): e0196057 doi: 10.1371/journal.pone.0196057
|
| 42 |
S. Panicker, C.P. Girish Kumar, V. Selvaraj, R. Prabu, C. Chandrasekar, A.S. Valan, J. Suria Kumar, K. Raja. Molecular epidemiology of HBV among HIV infected individuals in Chennai, south India. Virus Research 2021; 300: 198439 doi: 10.1016/j.virusres.2021.198439
|
| 43 |
Ya-Hui Huang, Kung-Hao Liang, Rong-Nan Chien, Tsung-Hui Hu, Kwang-Huei Lin, Chao-Wei Hsu, Chih-Lang Lin, Tai-Long Pan, Po-Yuan Ke, Chau-Ting Yeh. A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00631-9
|
| 44 |
Ann‐Sofi Duberg, Charlotte Lybeck, Anna Fält, Scott Montgomery, Soo Aleman. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study. Hepatology Communications 2022; 6(9): 2418 doi: 10.1002/hep4.1974
|
| 45 |
Françoise Lunel-Fabiani, Wael Mansour, Abdellahi Ould Amar, Mohamed Aye, Frédéric Le Gal, F- Zahra Fall Malick, Lô Baïdy, Ségolène Brichler, Pascal Veillon, Alexandra Ducancelle, Emmanuel Gordien, Michel Rosenheim. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: A cross sectional study. Journal of Infection 2013; 67(5): 448 doi: 10.1016/j.jinf.2013.06.008
|
| 46 |
Ana Isabel Gil-García, Antonio Madejón, Irene Francisco-Recuero, Ana López-López, Emiliana Villafranca, Miriam Romero, Araceli García, Antonio Olveira, Rocío Mena, Juan Ramón Larrubia, Javier García-Samaniego. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment. World Journal of Gastroenterology 2019; 25(38): 5883-5896 doi: 10.3748/wjg.v25.i38.5883
|
| 47 |
C. Wendy Spearman, Ronalda de Lacy, Elizabeth Goddard. Viral Infections in Children, Volume II. 2017; : 177 doi: 10.1007/978-3-319-54093-1_7
|
| 48 |
José Ángel Cuenca-Gómez, Ana Belén Lozano-Serrano, María Teresa Cabezas-Fernández, Manuel Jesús Soriano-Pérez, José Vázquez-Villegas, Matías Estévez-Escobar, Isabel Cabeza-Barrera, Joaquín Salas-Coronas. Chronic hepatitis B genotype E in African migrants: response to nucleos(t)ide treatment in real clinical practice. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3469-y
|